Retatrutide is an investigational compound that has not been approved by the FDA, so it does not belong in a sentence describing which agents the agency restricts to prescription status alongside semaglutide and tirzepatide
At NOCO Healthcare, we take the time to understand your health history, weight loss goals, and lifestyle before recommending a treatment plan
Prevents Chronic Illness Nearly every person with some sort of chronic illnesslike Parkinsons Disease, heart disease, chronic fatigue syndrome, arthritis, and cancerhas one similar characteristic: Theyre low on glutathione
While generic solvents can "crash" sensitive peptides, our custom-formulated BAC water is pH-optimized to ensure even the most delicate molecules remain stable and clear
Despite the promising potential of GLP-1 RAs, it is essential to conduct further clinical studies to confirm their long-term efficacy and safety in patients with HFpEF
We need to get more doctors trained in the matter to properly guide patients